Gk-nav

Gk-nav has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 15, 2025: “Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on gk-nav

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Technology Development
  • Animals1

What did studies of gk-nav find?

4

Studies of gk-nav measured 4 outcomes, among them CD8+ T cells, cardiac dysfunction and metabolic disease.

CD8+ T cells

upin mouse cells1

1 study
  1. Gk-nav activates CD8+ T cells in mouse cells (bone marrow-derived dendritic cells co-cultured in vitro).

    “promoting DCs maturation and activation of CD8+T cells in vitro”

    Cellsbone marrow-derived dendritic cells co-cultured in vitroself-assembled K36-Gpnmb fusion nanovaccine

    Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction

    Human vaccines & immunotherapeutics

Cardiac dysfunction

downin mice1

1 study
  1. Gk-nav decreases cardiac dysfunction in mice (high-fat diet-induced progeroid mice).

    “leading to a significant improvement in age-related metabolic disorders in adipose tissue and cardiac dysfunction”

    Animalshigh-fat diet-induced progeroid miceself-assembled K36-Gpnmb fusion nanovaccineheart

    Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction

    Human vaccines & immunotherapeutics

More on Cardiac dysfunction

Metabolic disease

downin mice1

1 study
  1. Gk-nav decreases metabolic disease in mice (high-fat diet-induced progeroid mice).

    “leading to a significant improvement in age-related metabolic disorders in adipose tissue and cardiac dysfunction”

    Animalshigh-fat diet-induced progeroid miceself-assembled K36-Gpnmb fusion nanovaccineadipose tissue

    Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction

    Human vaccines & immunotherapeutics

More on Metabolic disease

Cellular senescence

downin mice1

1 study
  1. Gk-nav decreases cellular senescence in mice (high-fat diet-induced progeroid mice; nanovaccine given by subcutaneous immunization).

    “the targeted anti-aging immunity triggered by GK-NaV demonstrated the ability to selectively eliminate senescent adipocytes and cardiomyocytes in high-fat diet (HFD)-induced progeroid mice”

    Animalshigh-fat diet-induced progeroid mice; nanovaccine given by subcutaneous immunizationself-assembled K36-Gpnmb fusion nanovaccineadipose tissue and heart

    Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction

    Human vaccines & immunotherapeutics

More on Cellular senescence

Latest